Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2009 2
2010 5
2011 1
2019 4
2020 3
2021 5
2022 2
2023 7
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Results by year

Filters applied: . Clear all
Page 1
Multiple Myeloma in 2023 Ways: From Trials to Real Life.
Fazio M, Del Fabro V, Parrinello NL, Allegra A, Markovic U, Botta C, Accardi F, Vincelli ID, Leotta S, Elia F, Esposito B, Garibaldi B, Sapuppo G, Orofino A, Romano A, Palumbo GA, Di Raimondo F, Conticello C. Fazio M, et al. Among authors: del fabro v. Curr Oncol. 2023 Nov 3;30(11):9710-9733. doi: 10.3390/curroncol30110705. Curr Oncol. 2023. PMID: 37999125 Free PMC article. Review.
Lactate trafficking inhibition restores sensitivity to proteasome inhibitors and orchestrates immuno-microenvironment in multiple myeloma.
Barbato A, Giallongo C, Giallongo S, Romano A, Scandura G, Concetta S, Zuppelli T, Lolicato M, Lazzarino G, Parrinello N, Del Fabro V, Fontana P, Aguennoz M, Li Volti G, Palumbo GA, Di Raimondo F, Tibullo D. Barbato A, et al. Among authors: del fabro v. Cell Prolif. 2023 Apr;56(4):e13388. doi: 10.1111/cpr.13388. Epub 2023 Feb 15. Cell Prolif. 2023. PMID: 36794373 Free PMC article.
Clinical outcome of SARS-CoV-2 infections occurring in multiple myeloma patients after vaccination and prophylaxis with tixagevimab/cilgavimab.
Duminuco A, Romano A, Leotta D, La Spina E, Cambria D, Bulla A, Del Fabro V, Tibullo D, Giallongo C, Palumbo GA, Conticello C, Di Raimondo F. Duminuco A, et al. Among authors: del fabro v. Front Oncol. 2023 Mar 29;13:1157610. doi: 10.3389/fonc.2023.1157610. eCollection 2023. Front Oncol. 2023. PMID: 37064138 Free PMC article.
CXCL12/CXCR4 axis supports mitochondrial trafficking in tumor myeloma microenvironment.
Giallongo C, Dulcamare I, Tibullo D, Del Fabro V, Vicario N, Parrinello N, Romano A, Scandura G, Lazzarino G, Conticello C, Li Volti G, Amorini AM, Musumeci G, Di Rosa M, Polito F, Oteri R, Aguennouz M, Parenti R, Di Raimondo F, Palumbo GA. Giallongo C, et al. Among authors: del fabro v. Oncogenesis. 2022 Jan 21;11(1):6. doi: 10.1038/s41389-022-00380-z. Oncogenesis. 2022. PMID: 35064098 Free PMC article.
Myeloma Patient With Brugada Syndrome and Successful Lenalidomide Treatment.
Bellofiore C, Sapienza G, Markovic U, Del Fabro V, Romano A, Stagno F, Tamburino C, Mangiafico S, Di Raimondo F, Conticello C. Bellofiore C, et al. Among authors: del fabro v. Clin Lymphoma Myeloma Leuk. 2021 May;21(5):e456-e459. doi: 10.1016/j.clml.2020.12.022. Epub 2020 Dec 26. Clin Lymphoma Myeloma Leuk. 2021. PMID: 33531286 No abstract available.
29 results